혈액 및 혈액 성분 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Blood and Blood Components Market size is expected to reach USD 12.78 Billion in 2034 from USD 7.79 Billion (2025) growing at a CAGR of 5.66% during 2026-2034.

The Global Blood and Blood Components Market is growing due to the increasing demand for blood transfusions and advanced medical treatments. Blood components such as red blood cells, platelets, and plasma are widely used in surgeries, trauma care, cancer treatment, and the management of various medical conditions. Blood banks and healthcare institutions play a crucial role in collecting and distributing these life-saving components.

Market growth is driven by the rising number of surgical procedures, increasing prevalence of chronic diseases, and growing need for emergency medical care. Advances in blood storage technologies and improved screening methods are enhancing the safety and availability of blood products. Additionally, government initiatives encouraging blood donation are supporting the expansion of blood supply systems.

Looking ahead, the blood and blood components market is expected to grow as healthcare systems continue to improve and medical treatments become more advanced. Innovations in blood processing and storage technologies will enhance the efficiency of blood management systems. With increasing global demand for safe and reliable blood supplies, the market is projected to experience sustained growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Whole Blood
• Red Blood Cells
• Platelets
• Plasma
• Others

By Application

• Therapeutic
• Diagnostic
• Research

By End-User

• Hospitals
• Blood Banks
• Diagnostic Laboratories
• Research Institutes

COMPANIES PROFILED

• American Red Cross, Canadian Blood Services, Terumo Blood and Cell Technologies Terumo BCT, Grifols, SA, CSL Behring, Octapharma AG, Kedrion Biopharma Inc, China Biologic Products Holdings Inc, B Braun Melsungen AG, Haemonetics Corporation, Fresenius Kabi AG, Sanquin Blood Supply Foundation, Cerus Corporation, Bio Rad Laboratories Inc, Immucor Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BLOOD AND BLOOD COMPONENTS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Whole Blood Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Red Blood Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Platelets Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Plasma Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BLOOD AND BLOOD COMPONENTS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Therapeutic Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Diagnostic Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Research Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BLOOD AND BLOOD COMPONENTS MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Blood Banks Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BLOOD AND BLOOD COMPONENTS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Application
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Application
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Application
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Application
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Application
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL BLOOD AND BLOOD COMPONENTS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 American Red Cross
  • 9.2.2 Canadian Blood Services
  • 9.2.3 Terumo Blood And Cell Technologies (Terumo BCT)
  • 9.2.4 Grifols, S.A
  • 9.2.5 CSL Behring
  • 9.2.6 Octapharma AG
  • 9.2.7 Kedrion Biopharma Inc
  • 9.2.8 China Biologic Products Holdings Inc
  • 9.2.9 B. Braun Melsungen AG
  • 9.2.10 Haemonetics Corporation
  • 9.2.11 Fresenius Kabi AG
  • 9.2.12 Sanquin Blood Supply Foundation
  • 9.2.13 Cerus Corporation
  • 9.2.14 Bio Rad Laboratories Inc
  • 9.2.15 Immucor Inc